Abstract
The use of drugs in Western societies has been associated with male gender roles and behaviors and is poorly regarded in female behavior. For men, drug use has most often been regarded as a risk behavior, a deviation, or an illness when serious consequences for health arise. On the other hand, for women, drug use has been viewed as a vice, a disease, a response to female problems or disorders, and, above all, as a transgression of women’s traditional roles.
The vulnerability of women is exacerbated by their invisibility: few resources are allocated to cover the needs of female drug users; there is a shortage of staff trained on gender matters; treatments begin at a late stage; a growing number of women are imprisoned in men’s prisons; few if any women hold responsible positions in drug user associations, etc. Thus, the invisibility that exacerbates their vulnerability results in complete exclusion in some cases. At the same time, the invisibility of female drug users is not only obvious when they are the object of policies but also when they are the subject.
We can foresee that as a gender approach is incorporated into the policy guidelines designed and issued by the various organizations dedicated to drafting drug policies in the European Union, and as these guidelines are effectively applied by the member States, we will be able to obtain clearer information about the problematic uses and the contexts in which drugs are used and about the treatment programs and accessibility by all the people who need such programs, which also cover women’s needs, with their strategies and resources.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
In the surveys, drug use is associated with a temporal frequency: use in the last month, use in the last year and use at some point in one’s life or so-called lifetime prevalence. In this work we will look at annual frequency as these data are available to us in various works.
- 2.
Various sources and approximative data are available for estimating the problems associated with drugs and drug dependency. In this case, we will use an indirect indicator, the request for treatment from SEIT, the Government System of Information on Drug Addicts of Spain's National Drug Strategy (PNsD). We understand that a drug user who requests treatment does so because s/he has a problem with the use of one or more psychotropic substances. We are aware of the limitations of this indicator, as not all the people who use drugs and have problems with drugs, or feel dependent upon them, seek treatment.
- 3.
This reason appeared among younger groups of users who began using heroin in the 1990s, but we repeat again that this incidence involved a minority as there were other drugs with a better social image than heroin that could satisfy this motivation.
- 4.
Government System of Information on Drug Addicts. There are three indirect indicators: treatment indicator, emergency indicator, and the indicator of mortality related to illegal drugs.
References
Meneses C. Mujer y heroína. Un estudio antropológico de la heroinomanía femenina. Tesis doctoral. Departamento de Antropología y Trabajo Social. Universidad de Granada; 2001.
Romo N. La mirada de género en el abordaje de los usos y abusos de drogas. Revista Española de Drogodependencias. 2010;3:269–72.
Reed BG. Drug misuse and dependency in women: the meaning and implications of being considered a special population or minority group. Int J Addict. 1985;20(1):13–62.
Meneses C. Invisibilidad y estigmatización del consumo de drogas en las mujeres, en García-Mina, Ana; Carrasco, Mª José, editors. Diferencias de género en el uso de las drogas. Madrid: Universidad P Comillas; 2006.
Camí J. 2000. Las sustancias: farmacología. In: Grup Igia y cols, editors. Contextos, Sujetos y Drogas: Manual sobre Drogodependencias. Madrid: Institut Municipal de Salut Pública‐FAD; 2000, p. 159–85.
Kuntsche E, Rehm J, Gmel G. Characteristic of binge drinking in Europe. Soc Sci Med. 2004;59:113–27.
Wilsnack RW, Vogeltanz ND, Wilsnack SC, Harris TR. Gender differences in alcohol consumption and adverse drinking consequences: cross-cultural patterns. Addiction. 2000;95(2):251–65.
Meneses C y Charro B. en prensa. Es necesaria una intervención diferencial de género en la prevención universal y selectiva del consumo de drogas en adolescentes. Revista de Psiquiatría y Salud Mental. http://dx.org/10.1016/j.rpsm.2013.01.003
Romo N. Cultura del baile y riesgo: la influencia del género en los nuevos consumos de drogas de síntesis. Granada. Tesis doctoral, Departamento de Antropología y Trabajo Social, Universidad de Granada; 2001.
Romo N. Técno y Baile. Mitos y realidades de las diferencias de género. Revista de Estudios de Juventud. 2004;64:111–6.
Keane H. Intoxication, harm and pleasure: an analysis of the Australian National Alcohol Strategy. Crit Public Health. 2009;19(2):135–42.
Romo N, Vega A, Meneses C, Gil E, Markez I, Póo M. Sobre el malestar y la prescripción: un estudio sobre los usos de psicofármacos por las mujeres. Revista Española de Drogodependencias. 2003;28(4):372–9.
Markez I, Póo M, Romo N, Meneses C, Gil E, Vega A. Mujeres y psicofármacos: la investigación en atención primaria. Revista de la Asociación Española de Neuropsiquiatría. 2004;XXIV(91):39–61.
Goudsmit E. ¡Todo es mental! Puntos de vista estereotípicos y la psicologización de las enfermedades de la mujer, en Wilkinson S y Kitznger C. Mujer y Salud. Una perspectiva feminista. Barcelona. Paidós; 1996.
Comas D. El uso de drogas en la Juventud. Madrid: Ministerio de Cultura. Instituto de la Juventud; 1985.
EDIS. Consumo de alcohol y otras drogas en el colectivo femenino. Madrid: Instituto de la Mujer; 2000.
Burin M. Mujeres al borde de un ataque de psicofármacos [en línea]. http://old.clarin.com/diario/2000/08/31/o-02901.htm
Levinton ND. El superyo femenino. Maristarán. 2002;14:13–22.
Meneses C. Mujeres y consumo de opiáceos. Una realidad específica. Trastor Adict. 2006;8(4):261–75.
González DE. Consumo de Drogas en España. Madrid: Villalar; 1979.
Usó Arnal JC. Drogas y Cultura de Masas. (España 1855–1995). Tesis doctoral. Universidad Complutense de Madrid; 1995.
Meneses C. De la morfina a la heroína. El uso de drogas en la Juventud. Miscelánea Comillas. 2002;60(116):217–43.
Gamella J. Heroína en España (1977-1996). Claves de Razón Práctica. 1997;72:20–30.
Meneses C. Una atención específica para mujeres drogodependientes. Revista Proyecto. 2002;43:5–9.
Jiménez ML, Guzmán R. Género y usos de drogas: dimensiones de análisis e intersección con otros ejes de desigualdad. En: Diferencias invisibles: género, drogas y políticas públicas. Oñati Socio-Legal Series, vol. 2, no. 6; 2012.
Romo N, Gil E. Género y uso de drogas. De la ilegalidad a la legalidad para enfrentar el malestar. Trastor Adict. 2006;8(4):243–50.
Arana X, Markez I, Montañés V. Introducción al enfoque de género en las políticas europeas de drogas. En: Diferencias invisibles: género, drogas y políticas públicas. Oñati Socio-Legal Series, vol. 2, no. 6; 2012.
Consejo de la Unión Europea. 2008. Plan de Acción de la Unión Europea en materia de lucha contra la droga 2009-2012, Consejo de la Unión Europea, 2008/C 326/09, 20/12/2008.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Meneses, C., Markez, I. (2015). Use, Misuse, and Gender Differences. In: Sáenz-Herrero, M. (eds) Psychopathology in Women. Springer, Cham. https://doi.org/10.1007/978-3-319-05870-2_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-05870-2_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-05869-6
Online ISBN: 978-3-319-05870-2
eBook Packages: MedicineMedicine (R0)